KIESHA HARRIS: Open Payments
NPI 1780262014 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 10 payments from 8 companies in 2025. Trend: 2023 $48 · 2024 $318 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| HARMONY BIOSCIENCES LLC | 2 | $85 |
| Tris Pharma Inc | 2 | $34 |
| Alkermes, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| ABBVIE INC. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: WAKIX, REXULTI, Dyanavel XR, ARISTADA, Veozah, QULIPTA, UZEDY.
Industry payments across TN — which companies pay providers there.
